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The injection  of bacterial lipopolysaccharide  (LPS) 1 in mice causes the release of 
biological  mediators  into  the  serum.  High  concentrations  of factors  with  various 
biological effects are found in the serum of mice that were treated with Bacille bili~ 
de Calmette-Gu~rin (BCG) or Corynebacterium parvum before injection with LPS. Serum 
of mice  so-treated  is  called  tumor  necrosis  serum  (TNS),  because  it  causes  acute 
partial necrosis and subsequent regression of syngeneic tumor transplants in mice (1). 
In  addition  to  the  anti-tumor  effect,  TNS  influences  immunological  functions:  it 
contains factors that replace helper T  cells in the humoral immune response (2)  and 
that induce phenotypic and functional differentiation of B lymphocytes (3). 
In this report, we investigate the effect of TNS on the generation of cytotoxic cells 
in vitro. We show that two serologically distinct types of cytotoxic cells are generated 
in murine spleen-cell cultures  in the absence of specific stimulus.  One type arises in 
the presence of TNS and expresses the cell-surface antigen, Qa5, which is controlled 
by the Q region of chromosome  17  (4).  This cell does not express the T-cell surface 
marker Thy-1, in contrast to a second type that arises spontaneously in tissue culture. 
We refer to both types of nonspecific cytotoxic cells as natural killer (NK) cells. 
NK cells appear in murine spleens at ~3 wk of age and become undetectable ~3 
mo later (5, 6).  Serological studies indicate the expression of Thy-1  (7), Ly-5 (8), and 
NK (9)  cell-surface antigens on NK-cell populations.  A  number of reagents increase 
NK activity in young animals and induce reoccurrence of NK cells in older animals. 
Among these reagents are LPS (10), BCG (11), and C. parvum (12); substances that are 
prerequisites for the release of biologically active mediators in TNS (1). 
Materials and Methods 
Mice.  C57BL/6  and  BALB/c  mice  were  purchased  from  The Jackson  Laboratory,  Bar 
Harbor, Maine. BALB/c. nu mice were provided by Mr. C. Reeder, of the National Institutes 
of Health, Bethesda, Md. 
Reagents.  TNS  was  kindly  provided  by  E.  Richards,  of  the  Memorial  Sloan-Kettering 
Cancer Center,  New  York.  It was prepared as described  previously  (1)  by exsanguinating C. 
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parvum-treated mice (1 mg/mouse) 1 h after injection of LPS (20 #g/mouse). Mouse interferon 
(106 U/0.4 mg) was obtained from Dr. William Stewart, Jr. of the Memorial Sloan-Kettering 
Cancer Center. 
Cell Cultures.  Murine spleen cells were cultured at a cell concentration of 5 ×  106 cells/ml 
according to the method of Mishell and Dutton (13) except that 2-mercaptoethanol (5  ×  10  -5 
M) was added to the medium. 
Sera.  Monoclonal anti-Thy-l.2 antibody (clone 6/68)  and anti-Qa5 antibody (clone B16/ 
167) were prepared as described previously (4). For the removal of cells expressing  Thy-1 or 
Q a5,  spleen  cells  were  incubated  in  minimum  essential  medium  (containing  2%  fetal  calf 
serum)  for 45  min at  37°C  in  presence of antibody (1:100) and complement (C)  (nontoxic 
rabbit serum, diluted  1:10). Cells were washed twice,  and readjusted  to 5  ×  106 living cells 
before culture. In experiments aimed at determining the phenotype of effector cells, cultured 
spleen cells were treated similarly with antibody and C; however,  experimental populations 
(treated with antibody) were adjusted to the volume of control cells (treated with normal mouse 
serum [NMS]) containing 5  ×  106 cells/ml. 
Cytotoxicity  Test.  Target cells  (RIll,  BALB/c-derived, radiation-induced  leukemia cells, 
maintained in tissue culture) were incubated with 51Cr (100 #C/7  ×  106 cells in 0.5 ml culture 
medium) for 60 min, washed twice, and adjusted to 105 cells/ml. 0.1 ml of 5aCr-labeled target 
cells were mixed with 0.1 ml effector cells in ratios of 200:1, 40:1, 8:1, and 1.6:1. Cell mixtures 
were incubated for 6 h at 37°C with a gas mixture of 7% Oz, 10% COz, and 83% N2. Released 
51Cr activity was determined using a Titerteck supernate collection  system (Flow Laboratories, 
Inc., Rockville,  Md.)  and a  Packard gamma scintillation counter (Packard Instrument Co., 
Downers Grove, I11.). The percentage of cytotoxicity was calculated as described previously (5). 
Results and Discussion 
Spleens of athymic BALB/c.nu  mice contain  NK cells  (5,  14)  (Fig.  1).  NK cells 
lost, or at best maintained, cytotoxic activity in tissue culture. Addition of TNS to the 
culture medium induced  marked NK activity in culture of BALB/c.nu  spleen cells 
(Fig.  1). NK-cell activity in TNS-treated spleen-cell cultures reached a peak between 
day  1 and 2.  Spleen cells from mice with normal thymic function generated,  in the 
presence of TNS, two peaks of cytotoxic activity, one peak between day 1 and day 2, 
and a  second peak between day 4 and day 5.  In the absence of TNS, normal spleen 
cells generated only the later peak of NK-cell activity (Fig. 2 A). The failure of BALB/ 
c.nu  spleen cells to generate this second  peak of NK-cell activity indicated  that  T 
cells were required  for its generation. To verify this conclusion, we treated C57BL/6 
spleen  cells  with  anti-Thy-l.2  antibody  and  C  and  found  that  spleen  cells  thus 
depleted  of T  cells generate  early NK-cell activity in  response to stimulation  with 
TNS, but not the second peak of NK-cell activity (Fig.  2 B).  In screening a  series of 
monoclonal antibodies against distinct lymphocyte cell-surface components, we found 
one antibody (anti-Qa5) which lysed spleen ceils that were required for the generation 
of the  early  NK-cell  activity  (induced  by TNS)  but  which  did  not  abrogate  the 
generation  of later  NK  cells  that  arise  independently  of TNS  (Fig.  2 C).  Taken 
together, the data in Fig. 2 show that two populations of NK cells can be distinguished 
in murine spleens based on the requirements for their generation. One type depends 
on cells that express the Q a5 surface marker and requires TNS for its activation. The 
other type requires T  cells for its generation and arises in the absence of TNS. 
The phenotype of effector cells was determined in standard negative immunoselec- 
tive procedures using cells collected from cultures at the early (day 1) or the late (day 
4)  peak of NK-cell activity (Table I). Cells were obtained from spleen cultures that 
were  stimulated  with  TNS.  NK activity  from  spleen  cells  collected  on  day  1 was 
abrogated by treatment  with anti-Qa5 antibody and C, but  not  by treatment with 428  TUMOR  NECROSIS  SERUM  INDUCES  DISTINCT  NK  CELLS 
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Fro.  1.  Induction of nonspecific killer cells in cultures of BALB/c.nu spleen cells. BALB/c.nu 
cell suspensions (5  ×  l0  s cells/ml) were cultured in the presence (O)  or absence (O) of TNS (5 #1/ 
ml). Cells were harvested at times indicated and incubated with SlCr-labeled target cells in a  ratio 
of 100 spleen cells to  1 target cell. Each value was obtained from triplicate cultures, and the data 
shown represent the mean of three experiments. NMS or serum from mice treated with LPS or C. 
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Fio.  2.  Generation of NK cells in culture of C57BL/6 spleen cells after treatment with anti-Thy- 
1.2 antibody or anti-Qa5 antibody. Spleen cells were cultured in the absence (O) or presence (O) of 
TNS for the indicated time intervals and assayed for cytotoxic activity. Before culture, spleen cells 
were  treated  with:  (A)  NMS  (1:100)  and  C  (rabbit  serum  1:10);  (B)  monoclonal  anti-Thy-l.2 
antibody  (1:100)  and C;  (c)  monoclonal anti-Qa5 antibody  (1:100)  and C. Each point represents 
the mean of four experiments. CHUN,  PASANEN, HAMMERLING,  H,~MMERLING, AND IIOFFMANN 
TABLE  I 
Phenotype of In Vitro-Induced NK Cells 
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NK ceils collected at 
Percentage of cytotoxicity after treatment of cells 
with: 
NMS +  C  Anti-Thy-l.2  +  C  Anti-Qa5 +  C 
% 
Early peak (day 1)  41  +  9  27 ±  9  4 ±  3 
Late peak (day 4)  32 ±  11  16 ±  2  28 ±  5 
C57BL/6 spleen cells were cultured with TNS and harvested on day  1 or day 4 of 
culture. Before cytotoxic activity was determined, cells were incubated with either 
NMS  (1:100), monoclonal anti-Thy-l.2 antibody  (1:100), or monoclonal anti-Qa5 
antibody (1:100) and C (rabbit serum 1:10) for 45 rain at 37°C. The data represent 
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Flo. 3.  NK-cell  activity induced by interferon. BALB/c.nu spleen cells were cultured  in the 
presence of TNS (A) (5 #l/ml) or interferon (O) (U/ml as indicated). Spleen cells were harvested 
after 24 h in culture. Each value represents the mean of triplicate cultures from one experiment. 
anti-Thy-1 antibody and C. In contrast, spleen cells collected on day 4  did not lose 
.their  cytotoxic  activity  after  treatment  with  anti-Qa5  antibody,  but  showed  an 
increased sensitivity to  treatment with  anti-Thy-1 antibody. Treatment of effector 
cells with anti-Thy-1 antibody did not, however, discriminate between the two types 
of NK cells as decisively as treatment of spleen cells before culture. It has been our 
experience in the past that cultured T  lymphocytes are more resistant to lysis with 
anti-Thy-  1 serum and C than fresh spleen T  cells. Therefore, our failure to completely 
remove in vitro-induced cytotoxic cells by treatment with anti-Thy-1 antibody and C 
does not necessarily indicate that these cytotoxic cells are not T  cells. 
Initial attempts were made to identify the component in TNS that is involved in 
the activation of NK cells in vitro. TNS contains substantial amounts of interferon 
(1).  Because this agent has been shown to activate NK cells (15,  16), we considered 
the possibility that it is the interferon in TNS that causes generation of NK cells in 
vitro. This view is supported by experiments in which interferon, like TNS, generated 
NK-cell  activity  of cultures  of  murine spleen  cells  within  the  first  24  h.  In  this 
response,  10  a U  of interferon were  equivalent to  5  #1  of TNS  (Fig.  3).  Interferon- 
induced NK cells expressed, like TNS-induced NK cells, Qa5 surface antigen (data 
not shown). 430  TUMOR  NECROSIS  SERUM  INDUCES  DISTINCT NK CELLS 
Our  data  indicate  the  existence  of two  types  of cytotoxic  cells  arising  in  tissue 
culture  in  the  absence  of specific  antigenic  stimulation.  We  refer  to  both  types  of 
nonspecific  cytotoxic  cells  as  NK  cells.  We  believe  that  our  results  will  make  it 
necessary to define the class of natural killer cells more precisely with regard to their 
lineage derivations. The present study provides some criteria for a definition in terms 
of phenotype and requirement  for their activation. 
The physiological role played by NK cells is not known. It has been speculated that 
NK  cells  are  involved  in  immune  surveillance  (17,  18).  If the  concept  of immune 
surveillance (19, 20) is valid, it must also apply to mice with defective thymic functions 
(BALB/c.nu  mice),  because  the  tumor  incidence  in  these  animals  is  not  increased 
(21,  22).  The observation  of an  NK cell  type that  arises  in  spleen  cell  populations 
from  athymic  as  well  as  normal  mice and  that  is  distinct  from  thymus-dependent 
cytotoxic  cells  is,  therefore,  significant  in  the  context  of the  immune  surveillance 
concept. 
Summary 
Murine spleen cells generate nonspecific cytotoxic cells, referred to as natural killer 
(NK)  cells,  within  4  d  of incubation  in  Mishell-Dutton  cultures.  This  NK cell  type 
does not arise in cultures of BALB/c.nu spleen cells or in cultures of T-cell depleted 
C57BL/6 spleen cells, indicating that its activation depends on T  cells. Another type 
of NK cells is induced by tumor necrosis serum in murine spleen-cell cultures. It arises 
within  24  h  and  its  activation  does  not  depend  on T  cells.  This  cell  type  (and  its 
precursor)  expresses  the  recently  discovered cell-surface  marker  Qa5  (controlled  by 
the Q region of chromosome 17) that distinguishes this NK cell from the NK cell that 
depends  for its  activation  on  thymic  function.  Qa5 +  NK cells  are  also  induced  by 
interferon. 
Received  for publication 1 May 1976. 
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